Marshall Wace, LLP Zai Lab LTD Transaction History

Marshall Wace, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $375,932 - $589,456	14,859 New	14,859 $412,000
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $1.73 Million - $2.62 Million	-50,597 Reduced 85.31%	8,710 $298,000
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $1.17 Million - $2.51 Million	50,597 Added 580.91%	59,307 $2.06 Million
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $12 Million - $27.8 Million	-431,419 Reduced 98.02%	8,710 $383,000
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $10.5 Million - $20 Million	190,448 Added 76.28%	440,129 $27.7 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $25.8 Million - $43.9 Million	246,076 Added 6825.96%	249,681 $26.3 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $451,021 - $648,900	3,605 New	3,605 $638,000
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $8.41 Million - $12.8 Million	-66,617 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $5.46 Million - $9.02 Million	66,617 New	66,617 $9.02 Million
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $69,324 - $117,192	-1,420 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $43,267 - $53,463	1,420 New	1,420 $46,000
Q2 2019 Aug 14, 2019	SELL	$25.73 - $35.79 $109,198 - $151,892	-4,244 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $4.02 Million - $6.65 Million	-268,838 Reduced 98.45%	4,244 $99,000
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $4.86 Million - $6.92 Million	273,082 New	273,082 $5.32 Million

125

49.6M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.